Skip to main content
. 2022 Jun 14;14(6):1265. doi: 10.3390/pharmaceutics14061265

Figure 3.

Figure 3

(A) Loading efficiency (LE%) and encapsulating efficiency (EE%) of SIM@HA-MSN (n = 3). (B) XRD spectrum and (C) DSC analysis of bare MSN, SIM, and SIM@HA-MSN. (D) In vitro drug release of free SIM, SIM@MSN, and SIM@HA-MSN in the presence or absence of HAase (100 U/mL) (n = 3).